NIH Modular R01s in Cancer Control and Population Sciences (PA-25-172) – February 2027 cycle
PA-25-172 is a National Cancer Institute funding opportunity for modular R01 applications in cancer control and population sciences, with 5 February 2027 as the due date for new applications and 5 March 2027 for renewals, resubmissions and revisions. This guide covers research areas consistent with the scheme, readiness checks, project ideas and points to confirm in the funding opportunity announcement.
The published deadline has passed. Check the official page in case it has been extended, or browse the open listings.
Key dates
- Application deadline
- 5 February 2027
- Details last checked
- 10 November 2026
About the call
- Funder
- National Institutes of Health (National Cancer Institute)
- Country
- United States
- Scheme type
- Project grant
- Funding
- As stated in the call documents
- Eligibility
- Eligible institutions may submit modular R01 applications for cancer control and population sciences research; 5 February 2027 is the due date for new applications (renewals, resubmissions and revisions are due 5 March 2027).
- Scope
- Public health and epidemiology
Topics consistent with the call
- Cancer prevention and risk reduction in defined populations
- Cancer screening uptake, early detection and follow-up of abnormal results
- Health behaviours such as tobacco use, diet and physical activity in cancer risk
- Cancer survivorship, quality of life and long-term outcomes
- Disparities in cancer incidence, care and outcomes across populations
- Implementation and dissemination of evidence-based cancer control interventions
Based on the published scope; the official page sets out the full themes and requirements.
Is your work a fit? Check before you apply
- The applicant organisation is eligible under the funding opportunity announcement.
- The research addresses cancer control or population sciences within NCI’s interests.
- The budget suits the modular format set out in the announcement.
- The correct due date applies: 5 February 2027 for new applications, 5 March 2027 for others.
- A complete, institutionally approved application is submitted before the relevant due date.
Why This Funding Call Matters
Cancer control and population sciences translate biological and clinical knowledge into measurable reductions in cancer burden through prevention, screening, survivorship care and reducing disparities. The modular R01 mechanism supports investigator-initiated projects of moderate scale, making it accessible to teams with focused, well-defined questions and a clear analytic plan. A standing programme announcement gives investigators regular opportunities to propose population-based studies in this area.
Who Should Apply
Academic backgrounds
- Cancer epidemiology
- Behavioural science
- Health services research
- Biostatistics
- Implementation science
Institutions and sectors
- US universities and schools of public health
- NCI-designated cancer centres
- Health systems and research institutes
- Community-based research organisations
What Reviewers Typically Value
- Clear questions with potential to reduce cancer incidence, morbidity or mortality at population level.
- Rigorous study designs and analysis plans proportionate to the modular budget.
- Attention to populations that experience a disproportionate cancer burden.
- Strong investigative teams with relevant expertise and preliminary work.
Ideas You Could Develop
Your Plan to the Deadline
A suggested schedule working back from 5 February 2027. Adjust it to the stage your work has reached.
By 11 Dec 2026
Read the call documents; confirm eligibility, budget limits, assessment criteria and institutional requirements.
By 25 Dec 2026
Agree the research question, aims, team and partners; contact your research office.
By 8 Jan 2027
Draft the case for support, methods, impact and budget.
By 22 Jan 2027
Obtain internal review, letters of support and institutional sign-off.
By 31 Jan 2027
Final checks against the funder’s guidance and formatting rules.
By 5 Feb 2027
Submit through the funder’s system before the deadline.
What you gain
- Funding for the research, team and resources it needs.
- Recognition from a competitive, peer-reviewed process.
- Reviewer feedback that strengthens future applications.
- A track record for larger grants and fellowships.
What happens after you apply
- Eligibility check: the funder confirms the application meets the call rules.
- Peer review: external reviewers assess the proposal against the published criteria.
- Panel: a committee ranks proposals; some schemes include an interview.
- Decision: outcomes are released on the funder’s timetable.
- Award: successful applicants agree terms and reporting requirements before starting.
What the Funder Are Looking For
The National Cancer Institute is looking for modular R01 projects in cancer control and population sciences, covering research that informs prevention, early detection, survivorship and the reduction of cancer burden in populations. Applications are likely to be assessed on significance, approach, investigators and environment under NIH peer review. Applicants should confirm eligibility, budget limits and research priorities in the official announcement and consult programme staff where helpful.
Expert help
How Pubrica Can Help
Pubrica’s subject specialists can help you prepare a competitive proposal, planned back from the deadline. You remain the author of your work.
FAQs
Questions Researchers Ask
The next published deadline is 5 February 2027. Dates can change, so confirm them on the official page before you plan your work.
The announcement indicates that renewals, resubmissions and revisions are due on 5 March 2027, with 5 February 2027 applying to new applications. Applicants should confirm dates and requirements in the official funding opportunity announcement.
Eligible institutions may submit modular R01 applications for cancer control and population sciences research; 5 February 2027 is the due date for new applications (renewals, resubmissions and revisions are due 5 March 2027). Confirm the full eligibility rules in the call documents.
Yes. Pubrica’s specialists can review, write, edit and format your proposal. You remain the author and the person responsible for the submission.
Sources
- National Institutes of Health (National Cancer Institute). (2026). NIH Modular R01s in Cancer Control and Population Sciences (PA-25-172) – February 2027 cycle. Retrieved 10 November 2026, from https://grants.nih.gov/grants/guide/pa-files/PA-25-172.html
How to cite this page
Pubrica Insights. (2026). NIH Modular R01s in Cancer Control and Population Sciences (PA-25-172) – February 2027 cycle. Pubrica. https://pubrica.com/insights/calls-and-conferences/nih-modular-r01s-in-cancer-control-and-population-sciences-pa-25-172-f/
Pubrica Insights. “NIH Modular R01s in Cancer Control and Population Sciences (PA-25-172) – February 2027 cycle.” Pubrica, 2026, https://pubrica.com/insights/calls-and-conferences/nih-modular-r01s-in-cancer-control-and-population-sciences-pa-25-172-f/.
Pubrica Insights (2026) NIH Modular R01s in Cancer Control and Population Sciences (PA-25-172) – February 2027 cycle. Pubrica. Available at: https://pubrica.com/insights/calls-and-conferences/nih-modular-r01s-in-cancer-control-and-population-sciences-pa-25-172-f/ (Accessed: 10 November 2026).
Pubrica Insights. NIH Modular R01s in Cancer Control and Population Sciences (PA-25-172) – February 2027 cycle [Internet]. Pubrica; 2026 [cited 2026 Nov 10]. Available from: https://pubrica.com/insights/calls-and-conferences/nih-modular-r01s-in-cancer-control-and-population-sciences-pa-25-172-f/
Funding call